Trump directs FDA to limit DTC drug advertising, with legal challenges sure to follow

President Donald Trump has delivered another blow in his ongoing battle with the pharma industry, signing a memorandum on Tuesday that directs the FDA to rein in direct-to-consumer (DTC) drug advertising.The initiative, which has long been a priority for Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., is designed to roll back a 1997 policy shift that gave drugmakers a greater ability to advertise their products on television by relaxing the requirements on the information they must reveal about a treatment’s side effects.In his directive, Trump cited the power of the FDA—vested by Congress in 1962—to regulate drug...